CONMED Corporation Announces Second Quarter 2015 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/10/2026
- Nasdaq ends sharply higher; chip surge offsets Iran worries
- Software stocks slide as Starbucks builds AI tools to replace vendor software
- Applied Materials surges as CEO signals multi-year chip boom
- Oil prices settle 2% lower as economic worries outweigh supply risks
- Meta falls as massive AI infrastructure spending plans overshadow chip progress
- Key things to know ahead of SK Hynix’s blockbuster US listing
- Meta falls as massive AI infrastructure spending plans overshadow chip progress
- S&P Downgrades Oracle To 'bbb-/A-3'; Outlook Stable
- Software stocks slide as Starbucks builds AI tools to replace vendor software
- Citi names top picks in software ahead of Q2 earnings
Northland Capital Markets Downgrades CONMED (CNMD) to Market Perform
July 22, 2015 7:19 AM EDTNorthland Capital Markets downgraded CONMED (NASDAQ: CNMD) from Outperform to Market Perform with a price target of $58.00 (from $65.00), saying 2nd-half guidance may be too optimistic.
Analyst Mark Landy commented, "CNMD reported in line 2Q revenues of $181M but missed our and the... More
Needham & Company Raises Price Target to $60 Following Conmed's (CNMD) 2Q Miss
July 22, 2015 6:58 AM EDTNeedham & Company reiterated a Buy rating on CONMED (NASDAQ: CNMD), and raised the price target to $60.00 (from $56.00), following 2Q15. CNMD's reported revenue was $181.0M vs. consensus of $182.3M. EPS was $0.36 vs. consensus of $0.44. Analyst Mike Matson said that investors may give management the benefit of... More
Conmed (CNMD) Misses Q2 EPS by 8c, Maintains FY15 Guidance
July 21, 2015 4:04 PM EDTConmed (NASDAQ: CNMD) reported Q2 EPS of $0.36, $0.08 worse than the analyst estimate of $0.44. Revenue for the quarter came in at $181 million versus the consensus estimate of $182.6 million.
2015 Outlook
The Company reiterated its previously disclosed constant currency sales guidance, which calls... More

